These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12492023)

  • 21. [HIV and AIDS: experiencing the symptoms. What cell count and viral burden do not tell us].
    Holzhemer WL
    Servir; 2003; 51(3):127-32. PubMed ID: 12889249
    [No Abstract]   [Full Text] [Related]  

  • 22. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
    Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
    HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maintaining antiretroviral therapy reduces the risk of AIDS-defining events in patients with uncontrolled viral replication and profound immunodeficiency.
    Kousignian I; Abgrall S; Grabar S; Mahamat A; Teicher E; Rouveix E; Costagliola D;
    Clin Infect Dis; 2008 Jan; 46(2):296-304. PubMed ID: 18171266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocyte subsets and viral load in male AIDS patients with major depression: naturalistic study.
    Huang TL; Leu HS; Liu JW
    Psychiatry Clin Neurosci; 2006 Dec; 60(6):687-92. PubMed ID: 17109702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Why are AIDS dissidents still making 15-year-old, long-refuted claims?
    Delaney M
    Nature; 2000 Nov; 408(6810):287. PubMed ID: 11099014
    [No Abstract]   [Full Text] [Related]  

  • 26. The relationship between virologic and immunologic responses in AIDS clinical research using mixed-effects varying-coefficient models with measurement error.
    Liang H; Wu H; Carroll RJ
    Biostatistics; 2003 Apr; 4(2):297-312. PubMed ID: 12925523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [HIV-1, 2].
    Adachi A; Ueno F; Fujita M
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():497-502. PubMed ID: 12718017
    [No Abstract]   [Full Text] [Related]  

  • 28. Evolution of HIV in Africa.
    Ewald PW
    Science; 1992 Jul; 257(5066):10. PubMed ID: 1352412
    [No Abstract]   [Full Text] [Related]  

  • 29. HIV causes AIDS: Koch's postulates fulfilled.
    O'Brien SJ; Goedert JJ
    Curr Opin Immunol; 1996 Oct; 8(5):613-8. PubMed ID: 8902385
    [No Abstract]   [Full Text] [Related]  

  • 30. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
    Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
    J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.
    Williams BG; Dye C
    Science; 2003 Sep; 301(5639):1535-7. PubMed ID: 12920302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune restoration disorders following HAART.
    Davaro RE; Himlan PH
    AIDS Read; 1999; 9(3):167-9. PubMed ID: 12728901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [AIDS in children (clinico-morphological aspects)].
    Iakovtsova AF; Sorokina IV; Korneĭko IV
    Pediatriia; 1991; (2):100-4. PubMed ID: 2057280
    [No Abstract]   [Full Text] [Related]  

  • 34. The impact of antiretroviral therapy on AIDS and survival.
    Lundgren JD; Mocroft A
    J HIV Ther; 2006 Jun; 11(2):36-8. PubMed ID: 16981594
    [No Abstract]   [Full Text] [Related]  

  • 35. 3rd International AIDS Society Conference.
    Das P
    Lancet Infect Dis; 2005 Sep; 5(9):541. PubMed ID: 16156006
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased NKG2A found in cytotoxic natural killer subset in HIV-1 patients with advanced clinical status.
    Zhang R; Xu J; Hong K; Yuan L; Peng H; Tang H; Ma P; Zhang Y; Xing H; Ruan Y; Shao Y
    AIDS; 2007 Dec; 21 Suppl 8():S9-17. PubMed ID: 18172398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can immune markers predict subsequent discordance between immunologic and virologic responses to antiretroviral therapy? Adult AIDS Clinical Trials Group.
    Spritzler J; Mildvan D; Russo A; Asthana D; Livnat D; Schock B; Kagan J; Landay A; Haas DW;
    Clin Infect Dis; 2003 Aug; 37(4):551-8. PubMed ID: 12905140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AIDS in Africa.
    Gilks CF
    Br J Hosp Med; 1996 Nov 6-19; 56(9):442-3. PubMed ID: 8937694
    [No Abstract]   [Full Text] [Related]  

  • 39. The HIV/AIDS pandemic--virology update.
    van Rensburg EJ
    SADJ; 2002 Dec; 57(11):438, 440. PubMed ID: 12674858
    [No Abstract]   [Full Text] [Related]  

  • 40. [The human immunodeficiency virus type 2 (HIV-2)].
    Soriano V; Tor J; Ribera A; Muga R
    Rev Clin Esp; 1990 May; 186(8):394-9. PubMed ID: 2236770
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.